Rimsky Denis, MD
Interventional Cardiology · Miami, FLNPI 1710399613
Payments from drug & device makers
Across 253 payments — averaging $4924.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$550K
- Amgen$369K
- Novartis$103K
- Genentech, Inc.$85K
- Boehringer Ingelheim International GmbH$74K
- Pfizer$28K
- plus $37K from 18 others
What the payments were for
- Speaking & faculty fees$1561%
- Grants$2,2509%
- Travel & lodging$14,81262%
- Food & beverage$6,78828%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 4 | $550,203 |
| Amgen | 3 | $368,829 |
| Novartis | 6 | $103,239 |
| Genentech, Inc. | 19 | $84,894 |
| Boehringer Ingelheim International GmbH | 62 | $73,729 |
| Pfizer | 4 | $28,171 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 1 | $13,354 |
| Biotronik Inc. | 36 | $11,889 |
| Medtronic | 46 | $2,897 |
| Abbott | 8 | $2,645 |
| Philips North America LLC | 6 | $1,802 |
| Edwards Lifesciences | 19 | $1,557 |
| Boston Scientific | 16 | $1,234 |
| Shockwave Medical, Inc | 8 | $411 |
| Asahi Intecc USA, Inc. | 2 | $223 |
| W. L. Gore & Associates, Inc. | 1 | $167 |
| Abiomed | 1 | $139 |
| Terumo Medical Corporation | 1 | $120 |
| Novo Nordisk | 1 | $117 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $109 |
| E.r. Squibb & Sons, L.L.C. | 1 | $99 |
| Chiesi USA, Inc. | 3 | $79 |
| Johnson & Johnson | 2 | $36 |
| Cvrx, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rivacor$2,202
- Edora$2,202
- Acticor$2,202
- US Und$1,759
- COREVALVE EVOLUT R$1,593
- Sentus$1,126
- Plexa$1,126
- Solia$1,076
- BioMonitor$1,076
- Edwards SAPIEN 3 Transcatheter Heart Valve$629
- ASAHI PTCA Guide Wire$223
- MyCareLink$188
- GENERAL VASCULAR ACCESS$186
- GORE CARDIOFORM Septal Occluder$167
- Trifecta GT Tissue Heart Valve$150
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$147
- WATCHMAN FLX$141
- Impella$139
- LUX-Dx Insertable Cardiac Monitor$130
- LEQVIO$125
How this compares
$1,245,967 in reported general payments places this provider in the 95th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Miami
- Pedro Martinez-ClarkMiami$1.7M
- Eduardo de MarchenaMiami$978K
- Ramon QuesadaMiami$593K
- Mauricio CohenMiami$351K
- Dominick AngiolilloJacksonville$4M
- Douglas SpriggsClearwater$3.2M
- Rakesh PrashadOcala$3.1M
- Aldo Martinez FleitesMiami Lakes$2.2M
- Rohit AminPensacola$2M
- Roberto CubedduNaples$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.